It’s a good day for the asthma community!
Genome Canada , along with the Canadian Institutes of Health Research’s Large-Scale Applied Research Project (LSARP) has awarded over $9 million to a team of top Canadian researchers who will leverage AllerGen’s CHILD Study to look for clues to the causes of childhood asthma in the microorganisms living in the intestines of infants.
One of the interesting findings from the CHILD Study was that children who grow up in farms, have lots of siblings, or attend day care in the first 6 months of their life (and are thus exposed to bacteria and viruses) are less likely to develop asthma. Conversely, babies given antibiotics which wipe out bacteria are more likely to develop asthma.
Dr. Stuart Turvey (UBC), CHILD Study Co-Director, will head up the 4 year study which will examine the microbiome found in 3,500 stool samples collected as part of the CHILD Study , in an effort to understand the role infant gut bacteria plays in developing childhood asthma.
Asthma Canada has partnered on this project as a knowledge user and we are proud to have helped Dr. Turvey’s team secure this grant. This is one of the many ways in which we support research.
To learn more about Asthma Canada’s brand new National Research Program, see below.